Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Parkinson’s Disease Treatment market report explains the definition, types, applications, major countries, and major players of the Parkinson’s Disease Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Merck (US)
Novartis AG (Switzerland)
Teva (Israel)
Dr Reddy’s (India)
Cipla (India)
GSK (UK)
Lundbeck (Denmark)
Upsher-Smith (US)
Intas (India)
Acadia (US)
Impax Laboratories (US)
1 A Pharma (India)
US WorldMeds (US)
Boehringer Ingelheim (Germany)
Valeant Pharmaceuticals (Canada)
UCB (Belgium)
AbbVie (US)
Strides (India)
Wockhardt (India)
Zydus Cadila (India)
Sun Pharma (India)
By Type:
Oral
Transdermal
Subcutaneous
Intestinal Infusion
By End-User:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Parkinson’s Disease Treatment Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Parkinson’s Disease Treatment Outlook to 2028- Original Forecasts
-
2.2 Parkinson’s Disease Treatment Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Parkinson’s Disease Treatment Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Parkinson’s Disease Treatment Market- Recent Developments
-
6.1 Parkinson’s Disease Treatment Market News and Developments
-
6.2 Parkinson’s Disease Treatment Market Deals Landscape
7 Parkinson’s Disease Treatment Raw Materials and Cost Structure Analysis
-
7.1 Parkinson’s Disease Treatment Key Raw Materials
-
7.2 Parkinson’s Disease Treatment Price Trend of Key Raw Materials
-
7.3 Parkinson’s Disease Treatment Key Suppliers of Raw Materials
-
7.4 Parkinson’s Disease Treatment Market Concentration Rate of Raw Materials
-
7.5 Parkinson’s Disease Treatment Cost Structure Analysis
-
7.5.1 Parkinson’s Disease Treatment Raw Materials Analysis
-
7.5.2 Parkinson’s Disease Treatment Labor Cost Analysis
-
7.5.3 Parkinson’s Disease Treatment Manufacturing Expenses Analysis
8 Global Parkinson’s Disease Treatment Import and Export Analysis (Top 10 Countries)
-
8.1 Global Parkinson’s Disease Treatment Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Parkinson’s Disease Treatment Export by Region (Top 10 Countries) (2017-2028)
9 Global Parkinson’s Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Parkinson’s Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Transdermal Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Intestinal Infusion Consumption and Growth Rate (2017-2022)
-
9.2 Global Parkinson’s Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Parkinson’s Disease Treatment Market Analysis and Outlook till 2022
-
10.1 Global Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.2.2 Canada Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.2.3 Mexico Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.2 UK Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.3 Spain Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.4 Belgium Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.5 France Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.6 Italy Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.7 Denmark Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.8 Finland Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.9 Norway Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.10 Sweden Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.11 Poland Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.12 Russia Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.3.13 Turkey Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.2 Japan Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.3 India Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.4 South Korea Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.5 Pakistan Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.6 Bangladesh Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.7 Indonesia Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.8 Thailand Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.9 Singapore Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.10 Malaysia Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.11 Philippines Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.4.12 Vietnam Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.5.2 Colombia Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.5.3 Chile Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.5.4 Argentina Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.5.5 Venezuela Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.5.6 Peru Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.5.7 Puerto Rico Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.5.8 Ecuador Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.6.2 Kuwait Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.6.3 Oman Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.6.4 Qatar Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.6.5 Saudi Arabia Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.6.6 United Arab Emirates Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.7.2 South Africa Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.7.3 Egypt Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.7.4 Algeria Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Parkinson’s Disease Treatment Consumption (2017-2022)
-
10.8.2 New Zealand Parkinson’s Disease Treatment Consumption (2017-2022)
11 Global Parkinson’s Disease Treatment Competitive Analysis
-
11.1 Merck (US)
-
11.1.1 Merck (US) Company Details
-
11.1.2 Merck (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Merck (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.1.4 Merck (US) Parkinson’s Disease Treatment Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Novartis AG (Switzerland)
-
11.2.1 Novartis AG (Switzerland) Company Details
-
11.2.2 Novartis AG (Switzerland) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Novartis AG (Switzerland) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.2.4 Novartis AG (Switzerland) Parkinson’s Disease Treatment Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Teva (Israel)
-
11.3.1 Teva (Israel) Company Details
-
11.3.2 Teva (Israel) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Teva (Israel) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.3.4 Teva (Israel) Parkinson’s Disease Treatment Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Dr Reddy’s (India)
-
11.4.1 Dr Reddy’s (India) Company Details
-
11.4.2 Dr Reddy’s (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Dr Reddy’s (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.4.4 Dr Reddy’s (India) Parkinson’s Disease Treatment Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Cipla (India)
-
11.5.1 Cipla (India) Company Details
-
11.5.2 Cipla (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Cipla (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.5.4 Cipla (India) Parkinson’s Disease Treatment Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 GSK (UK)
-
11.6.1 GSK (UK) Company Details
-
11.6.2 GSK (UK) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 GSK (UK) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.6.4 GSK (UK) Parkinson’s Disease Treatment Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Lundbeck (Denmark)
-
11.7.1 Lundbeck (Denmark) Company Details
-
11.7.2 Lundbeck (Denmark) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Lundbeck (Denmark) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.7.4 Lundbeck (Denmark) Parkinson’s Disease Treatment Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Upsher-Smith (US)
-
11.8.1 Upsher-Smith (US) Company Details
-
11.8.2 Upsher-Smith (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Upsher-Smith (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.8.4 Upsher-Smith (US) Parkinson’s Disease Treatment Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Intas (India)
-
11.9.1 Intas (India) Company Details
-
11.9.2 Intas (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Intas (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.9.4 Intas (India) Parkinson’s Disease Treatment Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Acadia (US)
-
11.10.1 Acadia (US) Company Details
-
11.10.2 Acadia (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Acadia (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.10.4 Acadia (US) Parkinson’s Disease Treatment Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Impax Laboratories (US)
-
11.11.1 Impax Laboratories (US) Company Details
-
11.11.2 Impax Laboratories (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Impax Laboratories (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.11.4 Impax Laboratories (US) Parkinson’s Disease Treatment Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 1 A Pharma (India)
-
11.12.1 1 A Pharma (India) Company Details
-
11.12.2 1 A Pharma (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 1 A Pharma (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.12.4 1 A Pharma (India) Parkinson’s Disease Treatment Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 US WorldMeds (US)
-
11.13.1 US WorldMeds (US) Company Details
-
11.13.2 US WorldMeds (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 US WorldMeds (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.13.4 US WorldMeds (US) Parkinson’s Disease Treatment Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Boehringer Ingelheim (Germany)
-
11.14.1 Boehringer Ingelheim (Germany) Company Details
-
11.14.2 Boehringer Ingelheim (Germany) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Boehringer Ingelheim (Germany) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.14.4 Boehringer Ingelheim (Germany) Parkinson’s Disease Treatment Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Valeant Pharmaceuticals (Canada)
-
11.15.1 Valeant Pharmaceuticals (Canada) Company Details
-
11.15.2 Valeant Pharmaceuticals (Canada) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Valeant Pharmaceuticals (Canada) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.15.4 Valeant Pharmaceuticals (Canada) Parkinson’s Disease Treatment Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 UCB (Belgium)
-
11.16.1 UCB (Belgium) Company Details
-
11.16.2 UCB (Belgium) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 UCB (Belgium) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.16.4 UCB (Belgium) Parkinson’s Disease Treatment Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 AbbVie (US)
-
11.17.1 AbbVie (US) Company Details
-
11.17.2 AbbVie (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 AbbVie (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.17.4 AbbVie (US) Parkinson’s Disease Treatment Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Strides (India)
-
11.18.1 Strides (India) Company Details
-
11.18.2 Strides (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Strides (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.18.4 Strides (India) Parkinson’s Disease Treatment Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Wockhardt (India)
-
11.19.1 Wockhardt (India) Company Details
-
11.19.2 Wockhardt (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Wockhardt (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.19.4 Wockhardt (India) Parkinson’s Disease Treatment Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Zydus Cadila (India)
-
11.20.1 Zydus Cadila (India) Company Details
-
11.20.2 Zydus Cadila (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Zydus Cadila (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.20.4 Zydus Cadila (India) Parkinson’s Disease Treatment Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Sun Pharma (India)
-
11.21.1 Sun Pharma (India) Company Details
-
11.21.2 Sun Pharma (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Sun Pharma (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
11.21.4 Sun Pharma (India) Parkinson’s Disease Treatment Product Portfolio
-
11.21.5 Recent Research and Development Strategies
12 Global Parkinson’s Disease Treatment Market Outlook by Types and Applications to 2028
-
12.1 Global Parkinson’s Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Transdermal Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Intestinal Infusion Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Parkinson’s Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Parkinson’s Disease Treatment Market Analysis and Outlook to 2028
-
13.1 Global Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.2.2 Canada Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.2.3 Mexico Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.2 UK Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.3 Spain Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.4 Belgium Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.5 France Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.6 Italy Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.7 Denmark Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.8 Finland Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.9 Norway Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.10 Sweden Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.11 Poland Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.12 Russia Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.3.13 Turkey Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.2 Japan Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.3 India Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.4 South Korea Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.8 Thailand Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.9 Singapore Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.11 Philippines Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.5.2 Colombia Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.5.3 Chile Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.5.4 Argentina Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.5.6 Peru Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.6.3 Oman Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.6.4 Qatar Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.7.2 South Africa Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.7.3 Egypt Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.7.4 Algeria Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Parkinson’s Disease Treatment Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Parkinson’s Disease Treatment
-
Figure of Parkinson’s Disease Treatment Picture
-
Table Global Parkinson’s Disease Treatment Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Parkinson’s Disease Treatment Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Transdermal Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
Figure Global Intestinal Infusion Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson’s Disease Treatment Consumption by Country (2017-2022)
-
Table North America Parkinson’s Disease Treatment Consumption by Country (2017-2022)
-
Figure United States Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Canada Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Mexico Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Parkinson’s Disease Treatment Consumption by Country (2017-2022)
-
Figure Germany Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure UK Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Spain Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Belgium Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure France Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Italy Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Denmark Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Finland Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Norway Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Sweden Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Poland Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Russia Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Turkey Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table APAC Parkinson’s Disease Treatment Consumption by Country (2017-2022)
-
Figure China Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Thailand Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Singapore Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Philippines Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table South America Parkinson’s Disease Treatment Consumption by Country (2017-2022)
-
Figure Brazil Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Colombia Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Chile Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Argentina Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Peru Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table GCC Parkinson’s Disease Treatment Consumption by Country (2017-2022)
-
Figure Bahrain Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Oman Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Qatar Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Africa Parkinson’s Disease Treatment Consumption by Country (2017-2022)
-
Figure Nigeria Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Africa Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Egypt Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Algeria Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Oceania Parkinson’s Disease Treatment Consumption by Country (2017-2022)
-
Figure Australia Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Parkinson’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Merck (US) Company Details
-
Table Merck (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Merck (US) Parkinson’s Disease Treatment Product Portfolio
-
Table Novartis AG (Switzerland) Company Details
-
Table Novartis AG (Switzerland) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG (Switzerland) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Novartis AG (Switzerland) Parkinson’s Disease Treatment Product Portfolio
-
Table Teva (Israel) Company Details
-
Table Teva (Israel) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva (Israel) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Teva (Israel) Parkinson’s Disease Treatment Product Portfolio
-
Table Dr Reddy’s (India) Company Details
-
Table Dr Reddy’s (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy’s (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Dr Reddy’s (India) Parkinson’s Disease Treatment Product Portfolio
-
Table Cipla (India) Company Details
-
Table Cipla (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Cipla (India) Parkinson’s Disease Treatment Product Portfolio
-
Table GSK (UK) Company Details
-
Table GSK (UK) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK (UK) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table GSK (UK) Parkinson’s Disease Treatment Product Portfolio
-
Table Lundbeck (Denmark) Company Details
-
Table Lundbeck (Denmark) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lundbeck (Denmark) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Lundbeck (Denmark) Parkinson’s Disease Treatment Product Portfolio
-
Table Upsher-Smith (US) Company Details
-
Table Upsher-Smith (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Upsher-Smith (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Upsher-Smith (US) Parkinson’s Disease Treatment Product Portfolio
-
Table Intas (India) Company Details
-
Table Intas (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Intas (India) Parkinson’s Disease Treatment Product Portfolio
-
Table Acadia (US) Company Details
-
Table Acadia (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acadia (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Acadia (US) Parkinson’s Disease Treatment Product Portfolio
-
Table Impax Laboratories (US) Company Details
-
Table Impax Laboratories (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Impax Laboratories (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Impax Laboratories (US) Parkinson’s Disease Treatment Product Portfolio
-
Table 1 A Pharma (India) Company Details
-
Table 1 A Pharma (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table 1 A Pharma (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table 1 A Pharma (India) Parkinson’s Disease Treatment Product Portfolio
-
Table US WorldMeds (US) Company Details
-
Table US WorldMeds (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table US WorldMeds (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table US WorldMeds (US) Parkinson’s Disease Treatment Product Portfolio
-
Table Boehringer Ingelheim (Germany) Company Details
-
Table Boehringer Ingelheim (Germany) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim (Germany) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Boehringer Ingelheim (Germany) Parkinson’s Disease Treatment Product Portfolio
-
Table Valeant Pharmaceuticals (Canada) Company Details
-
Table Valeant Pharmaceuticals (Canada) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals (Canada) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Valeant Pharmaceuticals (Canada) Parkinson’s Disease Treatment Product Portfolio
-
Table UCB (Belgium) Company Details
-
Table UCB (Belgium) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB (Belgium) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table UCB (Belgium) Parkinson’s Disease Treatment Product Portfolio
-
Table AbbVie (US) Company Details
-
Table AbbVie (US) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie (US) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table AbbVie (US) Parkinson’s Disease Treatment Product Portfolio
-
Table Strides (India) Company Details
-
Table Strides (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strides (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Strides (India) Parkinson’s Disease Treatment Product Portfolio
-
Table Wockhardt (India) Company Details
-
Table Wockhardt (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wockhardt (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Wockhardt (India) Parkinson’s Disease Treatment Product Portfolio
-
Table Zydus Cadila (India) Company Details
-
Table Zydus Cadila (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Zydus Cadila (India) Parkinson’s Disease Treatment Product Portfolio
-
Table Sun Pharma (India) Company Details
-
Table Sun Pharma (India) Parkinson’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma (India) Parkinson’s Disease Treatment Main Business and Markets Served
-
Table Sun Pharma (India) Parkinson’s Disease Treatment Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transdermal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intestinal Infusion Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parkinson’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Table North America Parkinson’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Parkinson’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure Germany Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Parkinson’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure China Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Parkinson’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure Brazil Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Parkinson’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Parkinson’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Parkinson’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure Australia Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Parkinson’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
